BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

LifeCycle Pharma 

100 Park Avenue
13th Floor
New York  New York  10017  U.S.A.
Phone: 646-200-8500 Fax: 212-867-9403


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
LifeCycle Pharma Passing of Extraordinary General Meeting - Change of Company Name to Veloxis Pharmaceuticals A/S and Election of New Board Member 7/7/2011 6:01:14 AM
LifeCycle Pharma Drug Works as Well as Rival at Lower Dose; Share Gains 6/21/2011 6:32:15 AM
LifeCycle Pharma to Present at the 13th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/11/2011 6:26:45 AM
LifeCycle Pharma Announces Positive Results of Phase 2 Clinical Trial for LCP-Tacro(TM) in De Novo Liver Transplant Patients 1/6/2011 7:43:42 AM
LifeCycle Pharma Announces Completion of Fully Subscribed Equity Offering 1/6/2011 7:34:24 AM
LifeCycle Pharma Announces Positive Results of Phase 2 Clinical Trial for LCP-Tacro in De Novo Liver Transplant Patients 1/6/2011 6:28:33 AM
LifeCycle Pharma Receives Special Protocol Assessment (SPA) From FDA for LCP-Tacro(TM) Pivotal Phase 3 Study in De Novo Kidney Transplant Patients 8/12/2010 9:39:57 AM
LifeCycle Pharma Submits the Phase 3 Protocol for LCP-Tacro(TM) (De No Kidney) to the FDA 12/23/2009 10:04:27 AM
LifeCycle Pharma Receives Notice of Allowance for U.S. Patent on Fenoglide(R) 12/17/2009 9:49:25 AM
LifeCycle Pharma Promotes Dr. William J. Polvino as New President and Chief Executive Officer 12/2/2009 6:33:33 AM
12345678910